Harbin Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 59.9% in First Half of 2022

Harbin Pharmaceutical Group Co.,Ltd. (哈药集团股份有限公司) (600664.SH) reported a net profit of 146.7 million yuan in the first half of 2022, down 59.9% year-on-year.

Meanwhile, the company posted 6.4 billion yuan in revenue, up 0.2% year-on-year.

At the end of the reporting period, it had 13 billion yuan in total assets and 8.4 billion yuan in total liabilities, with a liability-to-asset ratio of 64.6%.